Junling Zhang

发表

FGFR2-TSC22D1, a novel FGFR2 fusion gene identified in a patient with colorectal cancer: A case report

Shiqing Chen, Xiao-ming Kao, Xi Zhu, 2021, World journal of clinical cases.

The Durable Effect of Pyrotinib Plus Trastuzumab and Chemotherapy in HER2-Positive Gastric Cancer With Brain Metastases: A Case Report and Literature Review

Yun Zeng, Mengli Huang, Junling Zhang, 2022, Frontiers in Oncology.

Rectosigmoid-Junction Squamous Cell Carcinoma With pMMR/MSS Achieved a Partial Response Following PD-1 Blockade Combined With Chemotherapy: A Case Report

Lunqing Wang, Shiqing Chen, Yangyang Yu, 2021, Frontiers in Oncology.

Landscape of IDH1/2 mutations in Chinese patients with solid tumors: A pan‐cancer analysis

Xiang Huang, Wei Li, Kai Yuan, 2020, Molecular genetics & genomic medicine.

A Novel Intergenic LSM14A-RET Fusion Variant in a Patient With Lung Adenocarcinoma.

M. Xiao, Weidong Mao, Junling Zhang, 2020, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Clinical characteristics and prognostic value of the KRAS mutation in Chinese colorectal cancer patients

Feng Zhang, Yingting Liu, Wen-Wei Hu, 2021, The International journal of biological markers.

Expression of Human Epidermal Growth Factor Receptor-2 Status and Programmed Cell Death Protein-1 Ligand Is Associated With Prognosis in Gastric Cancer

Keran Sun, C. Nie, Beibei Chen, 2021, Frontiers in Oncology.

Camrelizumab plus gemcitabine and oxaliplatin (GEMOX) in patients with advanced biliary tract cancer: a single-arm, open-label, phase II trial

Xuehao Wang, Xiangcheng Li, Yanhong Gu, 2020, Journal for ImmunoTherapy of Cancer.

Efficacy of intra-arterial chemotherapy with sequential anti-PD-1 antibody in unresectable gastric cancer: A retrospective real-world study

Jiafei Li, Guoli Li, Mengli Huang, 2023, Frontiers in Oncology.

Abstract 5230: Neoadjuvant programmed cell death protein 1 inhibitors combined with chemotherapy in resectable esophageal squamous carcinoma: an open-label, single-arm study

Xin Yang, Mengli Huang, Junling Zhang, 2022, Cancer Research.

Efficacy and safety of abrocitinib and upadacitinib versus dupilumab in adults with moderate-to-severe atopic dermatitis: A systematic review and meta-analysis

Junling Zhang, Yanxia Zhao, Qin Gao, 2023, Heliyon.

ALK Rearrangement in Small-Cell Lung Cancer and Durable Response to Alectinib: A Case Report

Y. Zhuang, Shiqing Chen, Ning Sun, 2021, OncoTargets and Therapy.

Association of KDR mutation with better clinical outcomes in pan-cancer for immune checkpoint inhibitors.

Wei Wang, R. Guo, Fang Zhang, 2022, American journal of cancer research.

Hybrid Capture-based Genomic Profiling of Circulating Tumor DNA From Patients With Advanced Ovarian Cancer

Guoqiang Wang, Zhi-qin Jiang, Yangyang Yu, 2021, Pathology & Oncology Research.

Rare Combined Small Cell Lung Carcinoma and Lung Squamous Cell Carcinoma Response to PD-1 Inhibitor as Third-Line Therapy: A Case Report

Mengli Huang, Junling Zhang, Zhisheng Liu, 2023, Cancer Management and Research.

Individual Irinotecan Therapy Under the Guidance of Pre-Treated UGT1A1*6 Genotyping in Gastric Cancer

C. Nie, Beibei Chen, Junling Zhang, 2024, Technology in cancer research & treatment.

Cholinesterase is Associated With Prognosis and Response to Chemotherapy in Advanced Gastric Cancer

W. Ye, Quan-liang Yang, Junling Zhang, 2021, Pathology & Oncology Research.

TMED2-ALK, a Novel ALK Fusion Gene Identified in a Patient With Lung Adenocarcinoma.

M. Zheng, Junling Zhang, Ruo Chen, 2020, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.